Budget 2019–20: Improving Access to Medicines – expansion of the Continuous Glucose Monitoring program

This Budget fact sheet outlines how the Government will expand eligibility of the Continuous Glucose Monitoring (CGM) program to include people under 21 years of age with congenital hyperinsulinaemia.

The Government will expand eligibility of the Continuous Glucose Monitoring (CGM) program to include people under 21 years of age with congenital hyperinsulinaemia. Free access to CGM monitoring devices will help this high need group to better manage this difficult disease and further support their families and carers.

 

Improving Access to Medicines – expansion of the Continuous Glucose Monitoring program

About this resource

Publication date:
Publication type:
Fact sheet
Audience:
General public
Language:
English

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.